Orion Portfolio Solutions, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Orion Portfolio Solutions, LLC

$9.43 Billion
Q3 2024

A detailed history of Orion Portfolio Solutions, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 2,571 shares of REGN stock, worth $1.83 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,571

Previous 2,873 10.51%

Holding current value

$1.83 Million

Previous $3.02 Million 10.5%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$1024.09 - $1201.76 $309,275 - $362,931	-302 Reduced 10.51%	2,571 $2.7 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $121,881 - $147,824	138 Added 5.05%	2,873 $3.02 Million
Q1 2024 May 09, 2024	SELL	$902.69 - $993.35 $32,496 - $35,760	-36 Reduced 1.3%	2,735 $2.63 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $10 Million - $11.4 Million	-12,934 Reduced 82.36%	2,771 $2.43 Million
Q3 2023 Nov 01, 2023	SELL	$692.45 - $844.37 $767,927 - $936,406	-1,109 Reduced 6.6%	15,705 $12.9 Million
Q2 2023 Aug 17, 2023	BUY	$700.03 - $830.35 $1.5 Million - $1.78 Million	2,145 Added 14.62%	16,814 $12.1 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $9.69 Million - $11.5 Million	13,839 Added 1667.35%	14,669 $10.5 Million
Q1 2023 Aug 30, 2023	BUY	$680.49 - $826.97 $311,664 - $378,752	458 Added 2.72%	17,272 $14.2 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $494,716 - $601,207	-727 Reduced 46.69%	830 $681,000
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $118,589 - $128,753	168 Added 12.1%	1,557 $1.12 Million
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $177,930 - $224,539	310 Added 28.73%	1,389 $957,000
Q2 2022 Jul 14, 2022	BUY	$548.35 - $738.84 $64,156 - $86,444	117 Added 12.16%	1,079 $638,000
Q1 2022 May 19, 2022	BUY	$595.12 - $698.43 $11,902 - $13,968	20 Added 2.12%	962 $672,000
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $207,065 - $255,639	-381 Reduced 28.8%	942 $595,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $428,800 - $508,677	747 Added 129.69%	1,323 $801,000
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $945 - $1,117	2 Added 0.35%	576 $322,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $1.12 Million - $1.38 Million	-2,518 Reduced 81.44%	574 $272,000
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $483,083 - $614,059	1,010 Added 48.51%	3,092 $1.49 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $964,207 - $1.17 Million	1,770 Added 567.31%	2,082 $1.17 Million
Q2 2020 Aug 19, 2020	BUY	$493.32 - $643.92 $60,185 - $78,558	122 Added 64.21%	312 $195,000
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $11,093 - $16,316	33 Added 21.02%	190 $93,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $43,038 - $59,112	157 New	157 $59,000

Others Institutions Holding REGN

# of Institutions

1,484

Shares Held

83.7M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.

Account

Orion Portfolio Solutions, LLC Regeneron Pharmaceuticals, Inc. Transaction History